SCHEMBL24286535

SCHEMBL24286535

O=S(=O)(c1cccc(C2CC2)c1)N1CCOc2ccc(-c3cccc(Cl)c3)cc21

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CPT1A P50416 3/20 0.51
▸ CPT2 P23786 2/20 0.51
▸ HTR6 P50406 2/20 0.46
▸ CPT1B Q92523 2/20 0.46
▸ RORC P51449 2/20 0.45
▸ CYP3A4 P08684 1/20 0.45
▸ CYP2D6 P10635 1/20 0.45
▸ CYP11B1 P15538 1/20 0.41
▸ CYP11B2 P19099 1/20 0.41
▸ GPR119 Q8TDV5 2/20 0.40
▸ ALDH1A1 P00352 2/20 0.40
▸ LMNA P02545 1/20 0.40
▸ PKM P14618 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ TP53 P04637 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ KDM2B Q8NHM5 2/20 0.39
▸ MMP2 P08253 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24286419 0.90 CPT1A (0.60) CPT1ACPT2HTR6CPT1BRORC
SCHEMBL24286568 0.83 RORC (0.50) RORCCYP11B1CYP11B2PKMCYP2C9
SCHEMBL24286363 0.83 RORC (0.49) CPT1ACPT2HTR6CPT1BRORC
SCHEMBL24286198 0.82 RORC (0.63) CPT1ACPT2HTR6CPT1BRORC
SCHEMBL24286691 0.82 CPT1A (0.51) CPT1ACPT2HTR6CPT1BRORC
SCHEMBL24286447 0.80 CPT1A (0.51) CPT1ACPT2HTR6CPT1BRORC
SCHEMBL24286502 0.79 RORC (0.55) RORC
SCHEMBL24286256 0.78 CYP3A4 (0.53) CPT1ACPT2HTR6CPT1BRORC
SCHEMBL20957213 0.77 RORC (0.76) RORC
SCHEMBL20957211 0.77 RORC (0.76) RORC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3307738-B1 ARYL DIHYDRO-2H-BENZO[B][1,4]OXAZINE SULFONAMIDE AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORY AND THE TREATMENT OF DISEASE UNIV MICHIGAN REGENTS (US) 2022-04-20 — — EP disclosed
Send feedback